Form C - Offering Statement:
SEC Accession No. 0001670254-24-000209
Filing Date
2024-03-12
Accepted
2024-03-12 15:15:44
Documents
11

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 10607
2 document_1.pdf EX-99 6900265
3 document_2.pdf EX-99 3895044
4 document_3.pdf EX-99 9864564
5 document_4.pdf EX-99 9272854
6 document_5.pdf EX-99 4715677
7 document_6.pdf EX-99 3778337
8 document_7.pdf EX-99 560979
9 document_8.pdf EX-99 801192
10 document_9.pdf EX-99 3056571
11 documents_list.htm EX-99 123
  Complete submission text file 0001670254-24-000209.txt   57137222
Mailing Address 3032 NADINA DR. LOUISVILLE KY 40220
Business Address 3032 NADINA DR. LOUISVILLE KY 40220 (618) 974-8907
Innovative Therapeutix, Inc. (Filer) CIK: 0001908403 (see all company filings)

EIN.: 000000000 | State of Incorp.: KY | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-33781 | Film No.: 24741724